Page 1402 - Markets News
SCI soars 8% on near 3-fold jump in Q4 net
The shipping major reported a 183.9 per cent jump in Q4FY23 net profit to Rs 359.83 crore when compared with Rs 126.74 crore in Q4FY22
 "SCI soars 8% on near 3-fold jump in Q4 net")
Stocks to Watch on May 10: L&T, SpiceJet, SCI, Apollo Tyres, Tata Steel
Stocks to Watch today: In a major blow, lessors have approached aviation regulator DGCA for deregistration of three planes of SpiceJet
 "Stocks to Watch on May 10: L&T, SpiceJet, SCI, Apollo Tyres, Tata Steel")
HDFC Securities recommends to buy Mastek, CCL Products; here's why
According to the technical analyst, Mastek is placed above its 20, 50 and 100 days EMA, while CCL Products' indicators and oscillators have turned bullish on daily and weekly charts
 "HDFC Securities recommends to buy Mastek, CCL Products; here's why")
Charts hint near-term correction for Nifty FMCG, sell-on-rise approach apt
It is recommended that traders adopt a cautious approach while trading in Nifty FMCG index, given the overextended market conditions and the likelihood of a correction in the near term, said analyst
 "Charts hint near-term correction for Nifty FMCG, sell-on-rise approach apt")
Adani-Hindenburg row: SC to hear Sebi's plea seeking extension on May 12
Recently, Sebi moved an application in the court and sought six more months to ascertain possible violations related to misrepresentation of financials, circumvention of regulations
 "Adani-Hindenburg row: SC to hear Sebi's plea seeking extension on May 12")
Markets too optimistic on interest rate reversal, says Hechler-Fayd'herbe
Hechler-Fayd'herbe said it's not the time for investors to relax because there is quite a lot of uncertainty beneath the surface, whether it is on the geopolitical front or the economic outlook
 "Markets too optimistic on interest rate reversal, says Hechler-Fayd'herbe")
Sensex, Nifty end flat after choppy day; Indiabulls RE sinks 20%, Zomato 6%
CLOSING BELL: Among sectors, the Nifty PSU Bank index fell nearly 3 per cent, followed by the Nifty Realty index (close to 1 per cent)
 "Sensex, Nifty end flat after choppy day; Indiabulls RE sinks 20%, Zomato 6%")
Stock of this iron & steel products company has zoomed 102% in six weeks
Till 02:48 PM; a combined 9.8 million equity shares or 6.5 per cent of total equity of the company changed hands on the NSE and BSE.
 "Stock of this iron & steel products company has zoomed 102% in six weeks")
Birlasoft soars 9% on heavy volumes post better-than-expected Q4 results
Deal signings during the quarter at $286 million TCV have been the best during the year under review, Birlasoft said
 "Birlasoft soars 9% on heavy volumes post better-than-expected Q4 results")
IHCL, Kamat: Hotel stocks at 52-week high; check out the trading strategies
Shares of Kamat Hotels India are on the course to double this year, while Royal Orchid Hotels and Oriental Hotels have both gained 30 per cent each.
 "IHCL, Kamat: Hotel stocks at 52-week high; check out the trading strategies")
L&T Q4 preview: Strong order inflow may drive profit up to 90% higher QoQ
Larsen & Toubro Q4 result preview: BNP Paribas expects total order inflow to cross Rs 76,000 crore during the quarter
 "L&T Q4 preview: Strong order inflow may drive profit up to 90% higher QoQ")
BSE Midcap index nears 52-week high; outperforms Smallcap, Sensex
ABB, Alkem Lab, AU SFB, Cholamandalam Investment, Glenmark Pharma, IDFC First Bank, IGL, Indian Hotels, M&M Financial and Varun Beverages (VBL) hit their respective 52-week highs on the BSE.
Apar Industries slips 18% on profit booking posts Q4 results
In past one year, the stock zoomed 341 per cent, as against 14 per cent rise in the S&P BSE Sensex.
 "Apar Industries slips 18% on profit booking posts Q4 results")
Strong margin outlook key driver for consumer major Marico's gains
There could be a gradual uptick in volume and value growth in the current year
 "Strong margin outlook key driver for consumer major Marico's gains")
Mankind Pharma lists at 20% premium; should you buy, sell, or hold?
Shares of Mankind listed at Rs 1,300, a 20 per cent premium over its issue price of Rs 1,080 on the National Stock Exchange (NSE) and the BSE
 "Mankind Pharma lists at 20% premium; should you buy, sell, or hold?")
New phase of capex cycle to start soon, say analysts. Top stocks to bet on
Helped by a property upcycle, analysts at Jefferies believe various government initiatives are likely to drive capex going ahead
 "New phase of capex cycle to start soon, say analysts. Top stocks to bet on")
Mahanagar Gas hits 52-week high; soars 7% on margin improvement in Q4
The board recommended a final dividend of Rs 16 per equity share having face value of Rs 10 each (i.e. 160 per cent) for FY23.
 "Mahanagar Gas hits 52-week high; soars 7% on margin improvement in Q4")
Kansai Nerolac surges 10% on healthy Q4 earnings; recommends 1:2 bonus
The good growth in infrastructure, core sector as well as automobile and real estate is likely to have a positive effect on the overall demand of paint for the industry in the long run.
 "Kansai Nerolac surges 10% on healthy Q4 earnings; recommends 1:2 bonus")
Kansai Nerolac, Canara Bank, Mankind Pharma among top stocks to watch today
Stock to Watch on Tuesday, May 9: Canara Bank's net profit rose 90.6 per cent year-on-year (YoY) at Rs 3,175 crore in Q4FY23
 "Kansai Nerolac, Canara Bank, Mankind Pharma among top stocks to watch today")
Charts reveal bearish trend for Nifty Private Bank index in near-term
By maintaining a strict stop-loss limit and implementing a sell-on-rise approach, investors can navigate present market trends with ease and mitigate potential losses, said the technical analyst
 "Charts reveal bearish trend for Nifty Private Bank index in near-term")